Quantitative assessment of barriers to the clinical development and adoption of cellular therapies:A pilot study


There has been a large increase in basic science activity in cell therapy and a growing portfolio of cell therapy trials. However, the number of industry products available for widespread clinical use does not match this magnitude of activity. We hypothesize that the paucity of engagement with the clinical community is a key contributor to the lack of commercially successful cell therapy products. To investigate this, we launched a pilot study to survey clinicians from five specialities and to determine what they believe to be the most significant barriers to cellular therapy clinical development and adoption. Our study shows that the main concerns among this group are cost-effectiveness, efficacy, reimbursement, and regulation. Addressing these concerns can best be achieved by ensuring that future clinical trials are conducted to adequately answer the questions of both regulators and the broader clinical community.

Publication DOI: https://doi.org/10.1177/2041731414551764
Divisions: College of Health & Life Sciences > School of Biosciences
College of Health & Life Sciences
Additional Information: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).
Publication ISSN: 2041-7314
Full Text Link:
Related URLs: https://journal ... 041731414551764 (Publisher URL)
PURE Output Type: Review article
Published Date: 2014-09-22
Accepted Date: 2014-07-20
Authors: Davies, Benjamin M
Rikabi, Sarah
French, Anna
Pinedo-Villanueva, Rafael
Morrey, Mark E
Wartolowska, Karolina
Judge, Andrew
MacLaren, Robert E
Mathur, Anthony
Williams, David J
Wall, Ivan (ORCID Profile 0000-0001-6294-8348)
Birchall, Martin
Reeve, Brock
Atala, Anthony
Barker, Richard W
Cui, Zhanfeng
Furniss, Dominic
Bure, Kim
Snyder, Evan Y
Karp, Jeffrey M
Price, Andrew
Carr, Andrew
Brindley, David A


Export / Share Citation


Additional statistics for this record